Five H.B. Fuller Directors Buy Roughly $100,000 of Stock Each
The near-simultaneous purchases by five separate board members are an unusually concentrated show of insider confidence.
Five H.B. Fuller directors — Daniel Florness, Charles Lauber, Thomas Handley, Teresa Rasmussen Trangsrud and Srilata Zaheer — each disclosed purchases of roughly $98,800 to $100,160 in company stock.
Five directors bought nearly identical stock amounts
Each of five H.B. Fuller directors disclosed a purchase within about $1,300 of one another, an unusually tight cluster for insider filings.
Investing.com — All News, individual filings for Florness, Lauber, Handley, Rasmussen Trangsrud, and Zaheer
Use this chart
Free to embed with attribution:
<figure><a href="https://www.indy.finance/news/five-h-b-fuller-directors-buy-roughly-100-000-of-stock-each"><img src="https://www.indy.finance/news/five-h-b-fuller-directors-buy-roughly-100-000-of-stock-each/graphic.svg" alt="Five directors bought nearly identical stock amounts" width="1200" height="675"></a><figcaption>Five directors bought nearly identical stock amounts — <a href="https://www.indy.finance/news/five-h-b-fuller-directors-buy-roughly-100-000-of-stock-each">Indy Finance</a></figcaption></figure>If H.B. Fuller's next quarterly filing shows insiders selling rather than adding to positions, the reading of this cluster as a sustained confidence signal would be undermined.
- Investing.com — All NewsH.B. Fuller director Daniel L. Florness buys $100,160 in stockExternal ↗
- Investing.com — All NewsH.B. Fuller director Charles Lauber purchases $99,984 of stockExternal ↗
- Investing.com — All NewsH.B. Fuller director Thomas Handley buys $98,820 in stockExternal ↗
- Investing.com — All NewsH.B. Fuller director Teresa J. Rasmussen Trangsrud buys $99,984 in stockExternal ↗
- Investing.com — All NewsH.B. Fuller director Srilata Zaheer acquires $100,118 in stockExternal ↗
Produced automatically by the INDY NEWS Desk from the public wire sources cited above, and checked against them before publication. Market commentary, not investment advice.